Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Yixuan,Hu

第一单位： Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

作者： Yixuan,Hu ^[1] ; Yinxing,Zhu ^[2] ; Junfeng,Shi ^[1] ; Xiaowei,Wei ^[1] ; Cuiju,Tang ^[3] ; Xiaoxiang,Guan ^[4] ; Wenwen,Zhang ^[5]

作者单位： Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. ^[1] Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; Department of Radiation Oncology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China. ^[2] Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: tangcuiju2020@163.com. ^[3] Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, China. Electronic address: xguan@njmu.edu.cn. ^[4] Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: wwzhang1022@hotmail.com. ^[5]

关键词 Conventional breast cancer biomarkers Diagnostic indicator Prognosis Therapeutic efficacy TrxR